Organon wins FDA nod to expand use of Nexplanon birth control implant

The U.S. Food and Drug Administration (FDA) has approved a label expansion for Nexplanon to allow its manufacturer, Organon ...
Standard-Journal

Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) ...
MPR

Nexplanon Approved for Pregnancy Prevention for Up to 5 Years

Clinical data support a 5-year duration for the Nexplanon implant, with no reported pregnancies during the extended 2-year study period. The Food and Drug Administration (FDA) has extended the ...
Zacks Investment Research on MSN

Organon secures FDA approval extending NEXPLANON use to five years

Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
The American Journal of Managed Care

5 Birth Control Methods That Are Safe for Women to Use

Education on birth control and its potential adverse effects is vital to women choosing the type that best suits them. Skepticism surrounding hormonal birth control has been increasing nationwide, ...
WBUR

Primary care physicians can help solve the current birth control crisis

Just before the holidays, a patient was in my office for what I thought was going to be a routine appointment. After completing the exam, however, we started talking about what was really on her mind.